ChemoMetec ASOCSE:CHEMM +0.15%99 Days Inventory is 1,535.00 as of Dec. 2025, which is 282% above its 10-year median of 402.12. GuruFocus rates OCSE:CHEMM with a GF Score™ of 99/100 and a GF Value™ of kr549.65 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 786 Medical Devices & Instruments companies, ChemoMetec AS ranks worse than 99.11% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). ChemoMetec AS's Average Total Inventories for the
six
months ended in Dec. 2025 was kr108.0 Mil. ChemoMetec AS's Cost of Goods Sold for the
six
months ended in Dec. 2025 was kr12.8 Mil.
Hence, ChemoMetec AS's Days Inventory for the
six
months ended in Dec. 2025 was 1,535.00.
The historical rank and industry rank for ChemoMetec AS's Days Inventory or its related term are showing as below:
OCSE:CHEMM'
s Days Inventory Range Over the Past 10 Years
Min: 197.85 Med: 402.12 Max: 1930.57
Current: 1930.57
During the past 13 years, ChemoMetec AS's highest Days Inventory was 1930.57. The lowest was 197.85. And the median was 402.12.
OCSE:CHEMM's Days Inventory is ranked worse than 99.11% of 786
companies
in the Medical Devices & Instruments industry
Industry Median: 179.6
vs OCSE:CHEMM: 1930.57
ChemoMetec AS's Days Inventory
increased
from Dec. 2024 (1,099.74) to Dec. 2025 (1,535.00).
It might indicate that ChemoMetec AS's sales slowed down.
Inventory Turnover measures how fast the company turns over its inventory within a year.
ChemoMetec AS's Inventory Turnover for the
six
months ended in Dec. 2025 was 0.12.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ChemoMetec AS's Inventory-to-Revenue for the
six
months ended in Dec. 2025 was 0.43.
ChemoMetec AS (OCSE:CHEMM) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
ChemoMetec AS's Inventory Turnover for the
six
months ended in Dec. 2025 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
ChemoMetec AS's Inventory to Revenue for the
six
months ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
ChemoMetec AS Days Inventory Related Terms
ChemoMetec AS Days Inventory Historical Data
* Premium members only.
The historical data trend for ChemoMetec AS's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OCSE:CHEMM vs ABT, SYK, MDT: Days Inventory Comparison
For the Medical Devices subindustry, ChemoMetec AS's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ChemoMetec AS Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ChemoMetec AS's Days Inventory distribution charts can be found below:
* The bar in red indicates where ChemoMetec AS's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ChemoMetec AS (OCSE:CHEMM) has a Days Inventory of 1,535.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ChemoMetec AS and its competitors. This is 282% above median its historical median of 402.12. Over the past decade, ChemoMetec AS's Days Inventory has ranged from 197.85 to 1,930.57. According to the industry distribution chart, ChemoMetec AS ranks #779 out of 786 companies in the Medical Devices & Instruments industry, placing it in the top 99.1%.
Is ChemoMetec AS's Days Inventory too high?
ChemoMetec AS's current Days Inventory of 1,535.00 is 282% above median its 10-year median of 402.12. Over the past 10 years, this metric has ranged from a low of 197.85 to a high of 1,930.57. The Medical Devices & Instruments industry median Days Inventory is 179.60. ChemoMetec AS's value of 1,535.00 is 754.7% above this industry median. Based on the distribution chart, ChemoMetec AS ranks #779 out of 786 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, ChemoMetec AS has a GF Score™ of 99/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does ChemoMetec AS's Days Inventory compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, ChemoMetec AS ranks #779 out of 786 companies for Days Inventory. This places ChemoMetec AS in the lower half of its industry. The industry median Days Inventory is 179.60. ChemoMetec AS's value of 1,535.00 is 754.7% above this benchmark. Historically, ChemoMetec AS's own Days Inventory has ranged from 197.85 to 1,930.57 over the past decade. While the company's 10-year median is 402.12 vs. the industry median of 179.60, ChemoMetec AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.60, based on 786 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. ChemoMetec AS's current Days Inventory of 1,535.00 is 754.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on ChemoMetec AS and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ChemoMetec AS's current Days Inventory is 1,535.00, which is 282% above median its own 10-year median of 402.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ChemoMetec AS stock overvalued right now?
Based on GuruFocus' analysis, ChemoMetec AS (OCSE:CHEMM) is currently considered Modestly Undervalued. The stock's GF Value™ is kr549.65, compared to a current price of kr407.40 — trading 25.9% below its estimated fair value. The current Days Inventory is 1,535.00, which is 282% above median its 10-year median of 402.12 and 754.7% above the Medical Devices & Instruments industry median of 179.60. ChemoMetec AS's overall GF Score™ is 99/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For ChemoMetec AS (OCSE:CHEMM), the current Days Inventory is 1,535.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ChemoMetec AS (OCSE:CHEMM) Overvalued in 2026?
Based on GuruFocus' analysis, ChemoMetec AS stock appears to be undervalued.
The current stock price of kr407.40 is trading 25.9% below its estimated GF Value™ of kr549.65.
GuruFocus considers ChemoMetec AS to be Modestly Undervalued.
Key valuation signals for OCSE:CHEMM:
Days Inventory: 1,535.00 (282% above median its 10-year median of 402.12)
GF Value™: kr549.65 vs. price of kr407.40 (25.9% below fair value)
Industry Position: 754.7% above the Medical Devices & Instruments median (#779 of 786)
No single metric tells the full story. See the OCSE:CHEMM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ChemoMetec AS specializes in designing, developing, and producing instruments using patented technology in cell counting and evaluation. It is engaged in the manufacturing and marketing of analytical instruments used for quantitative analysis of cells in liquids. Its applications include Cell Analysis and counting of Mammalian Cells, Yeast Cells, and Sperm Cells. It provides platforms for the determination of viability and cell count of yeast, veterinary semen, mammalian cells, and somatic cells as well as image analysis. It has four segments instruments; consumables; services and others, and the majority of its revenue is generated from the Consumable segment.
99GF Score
Get the complete analysis for OCSE:CHEMM
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OCSE:CHEMM has been successfully added to your 
